This Is the Most Important Number From Novavax's Q1 Earnings

This Is the Most Important Number From Novavax's Q1 Earnings

Source: 
Motley Fool
snippet: 
  • Novavax reported its first-ever profit in its most recent quarterly results.
  • Sales from its vaccine totaled $586 million and were behind the strong numbers.
  • But investors need to look deeper and avoid relying on just the top and bottom lines.